New York State Common Retirement Fund
DNTH icon

New York State Common Retirement Fund’s Dianthus Therapeutics DNTH Stock Holding History

New York State Common Retirement Fund’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.85M Buy
60,048
+12,076
+25% +$1.05M 0.01% 1015
2026
Q1 		$4.03M Buy
47,972
+41,072
+595% +$2.38M 0.01% 1101
2025
Q4 		$284K Hold
6,900
– – ﹤0.01% 2147
2025
Q3 		$272K Buy
6,900
+2,800
+68% +$71.6K ﹤0.01% 2158
2025
Q2 		$76.4K Sell
4,100
-5,600
-58% -$105K ﹤0.01% 2816
2025
Q1 		$176K Hold
9,700
– – ﹤0.01% 2282
2024
Q4 		$211K Hold
9,700
– – ﹤0.01% 2269
2024
Q3 		$266K Hold
9,700
– – ﹤0.01% 2177
2024
Q2 		$251K Buy
+9,700
New +$233K ﹤0.01% 2332
2022
Q3 		– Sell
-15
Closed – – 3317
2022
Q2 		$0 Sell
15
-917
-98% -$22.7K ﹤0.01% 3488
2022
Q1 		$43K Hold
932
– – ﹤0.01% 3197
2021
Q4 		$66K Sell
932
-4
-0.4% -$402 ﹤0.01% 3170
2021
Q3 		$109K Sell
936
-673
-42% -$78.4K ﹤0.01% 3111
2021
Q2 		$252K Buy
1,609
+655
+69% +$120K ﹤0.01% 2943
2021
Q1 		$181K Buy
954
+231
+32% +$38.9K ﹤0.01% 2874
2020
Q4 		$91K Buy
723
+406
+128% +$46K ﹤0.01% 3059
2020
Q3 		$34K Hold
317
– – ﹤0.01% 3184
2020
Q2 		$38K Sell
317
-756
-70% -$107K ﹤0.01% 3174
2020
Q1 		$108K Hold
1,073
– – ﹤0.01% 2742
2019
Q4 		$260K Sell
1,073
-258
-19% -$48.2K ﹤0.01% 2609
2019
Q3 		$219K Hold
1,331
– – ﹤0.01% 2724
2019
Q2 		$314K Buy
1,331
+1,037
+353% +$256K ﹤0.01% 2606
2019
Q1 		$77K Hold
294
– – ﹤0.01% 3012
2018
Q4 		$27K Buy
+294
New +$40.1K ﹤0.01% 3140

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

New York State Common Retirement Fund's DNTH Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Dianthus Therapeutics (DNTH) stake by 25% in Q2 2026, buying an estimated $1.05M and bringing the position to 60,048 shares worth $5.85M. The position accounts for 0.01% of the portfolio, ranked #1015.

New York State Common Retirement Fund first reported a position in DNTH in Q4 2018 and has held it in 24 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • New York State Common Retirement Fund held 60,048 shares of Dianthus Therapeutics worth $5.85M as of Q2 2026.
  • New York State Common Retirement Fund bought 12,076 Dianthus Therapeutics shares in Q2 2026, an estimated $1.05M.
  • Dianthus Therapeutics made up 0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1015 holding.
  • New York State Common Retirement Fund first reported a position in Dianthus Therapeutics in Q4 2018 and has held it in 24 quarters since.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.